Global Veterinary Drugs Contract Manufacturing 麻豆原创 Growth (Status and Outlook) 2025-2031

Publication ID:

LPI07252862

Publication Date:

July 2, 2025

Pages:

139

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

IT Services [2]

Software [3]

Computing & Electronics [4]

Description:

The global Veterinary Drugs Contract Manufacturing market size is predicted to grow from US$ 3498 million in 2025 to US$ 4909 million in 2031; it is expected to grow at a CAGR of 5.8% from 2025 to 2031.
Veterinary drug contract manufacturing refers to a form of cooperation in which a veterinary drug business enterprise signs a contract with a veterinary drug manufacturer, and the manufacturer produces veterinary drug products in accordance with the contract, while the veterinary drug business enterprise is responsible for product sales. The veterinary drug contract manufacturing model is conducive to improving the utilization rate of existing resources on a larger scale and promoting the refinement, specialization and scale of the veterinary drug industry chain. It enables veterinary drug business enterprises to focus on core businesses such as marketing, sales and services, while handing over the production process to manufacturers with professional knowledge and experience, thereby improving overall operational efficiency.
United States market for Veterinary Drugs Contract Manufacturing is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Veterinary Drugs Contract Manufacturing is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Veterinary Drugs Contract Manufacturing is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Veterinary Drugs Contract Manufacturing players cover Vetio, AlphaVet Export, Fabbrica Italiana Sintetici, Veto-pharma, Parnell, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
The 鈥淰eterinary Drugs Contract Manufacturing Industry Forecast鈥� looks at past sales and reviews total world Veterinary Drugs Contract Manufacturing sales in 2024, providing a comprehensive analysis by region and market sector of projected Veterinary Drugs Contract Manufacturing sales for 2025 through 2031. With Veterinary Drugs Contract Manufacturing sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Veterinary Drugs Contract Manufacturing industry.
This Insight Report provides a comprehensive analysis of the global Veterinary Drugs Contract Manufacturing landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Veterinary Drugs Contract Manufacturing portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Veterinary Drugs Contract Manufacturing market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Veterinary Drugs Contract Manufacturing and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Veterinary Drugs Contract Manufacturing.
This report presents a comprehensive overview, market shares, and growth opportunities of Veterinary Drugs Contract Manufacturing market by product type, application, key players and key regions and countries.
Segmentation by Type:
Anti-Infectives
Anti-Inflammatory
Parasiticides
Analgesics
Sedatives
Others
Segmentation by Application:
Pets
Cattle
Poultry
Swine
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Vetio
AlphaVet Export
Fabbrica Italiana Sintetici
Veto-pharma
Parnell
Medical Products Laboratories
Univet
Oxi Pharma
Sterling Pharmaceutical Services
ACME Drugs
Kela Health
Friulchem S.p.A.
Sypharma Pty Ltd
Safapac
Custom Veterinary Services
LABIANA
Nedulix Biotech Private Limited
Argenta Global
Altar Life Sciences

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 麻豆原创 Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 麻豆原创 Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 麻豆原创 Estimation Caveats
2 Executive Summary
2.1 World 麻豆原创 Overview
2.1.1 Global Veterinary Drugs Contract Manufacturing 麻豆原创 Size (2020-2031)
2.1.2 Veterinary Drugs Contract Manufacturing 麻豆原创 Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for Veterinary Drugs Contract Manufacturing by Country/Region (2020, 2024 & 2031)
2.2 Veterinary Drugs Contract Manufacturing Segment by Type
2.2.1 Anti-Infectives
2.2.2 Anti-Inflammatory
2.2.3 Parasiticides
2.2.4 Analgesics
2.2.5 Sedatives
2.2.6 Others
2.3 Veterinary Drugs Contract Manufacturing 麻豆原创 Size by Type
2.3.1 Veterinary Drugs Contract Manufacturing 麻豆原创 Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global Veterinary Drugs Contract Manufacturing 麻豆原创 Size 麻豆原创 Share by Type (2020-2025)
2.4 Veterinary Drugs Contract Manufacturing Segment by Application
2.4.1 Pets
2.4.2 Cattle
2.4.3 Poultry
2.4.4 Swine
2.4.5 Others
2.5 Veterinary Drugs Contract Manufacturing 麻豆原创 Size by Application
2.5.1 Veterinary Drugs Contract Manufacturing 麻豆原创 Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global Veterinary Drugs Contract Manufacturing 麻豆原创 Size 麻豆原创 Share by Application (2020-2025)
3 Veterinary Drugs Contract Manufacturing 麻豆原创 Size by Player
3.1 Veterinary Drugs Contract Manufacturing 麻豆原创 Size 麻豆原创 Share by Player
3.1.1 Global Veterinary Drugs Contract Manufacturing Revenue by Player (2020-2025)
3.1.2 Global Veterinary Drugs Contract Manufacturing Revenue 麻豆原创 Share by Player (2020-2025)
3.2 Global Veterinary Drugs Contract Manufacturing Key Players Head office and Products Offered
3.3 麻豆原创 Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Veterinary Drugs Contract Manufacturing by Region
4.1 Veterinary Drugs Contract Manufacturing 麻豆原创 Size by Region (2020-2025)
4.2 Global Veterinary Drugs Contract Manufacturing Annual Revenue by Country/Region (2020-2025)
4.3 Americas Veterinary Drugs Contract Manufacturing 麻豆原创 Size Growth (2020-2025)
4.4 APAC Veterinary Drugs Contract Manufacturing 麻豆原创 Size Growth (2020-2025)
4.5 Europe Veterinary Drugs Contract Manufacturing 麻豆原创 Size Growth (2020-2025)
4.6 Middle East & Africa Veterinary Drugs Contract Manufacturing 麻豆原创 Size Growth (2020-2025)
5 Americas
5.1 Americas Veterinary Drugs Contract Manufacturing 麻豆原创 Size by Country (2020-2025)
5.2 Americas Veterinary Drugs Contract Manufacturing 麻豆原创 Size by Type (2020-2025)
5.3 Americas Veterinary Drugs Contract Manufacturing 麻豆原创 Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Veterinary Drugs Contract Manufacturing 麻豆原创 Size by Region (2020-2025)
6.2 APAC Veterinary Drugs Contract Manufacturing 麻豆原创 Size by Type (2020-2025)
6.3 APAC Veterinary Drugs Contract Manufacturing 麻豆原创 Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Veterinary Drugs Contract Manufacturing 麻豆原创 Size by Country (2020-2025)
7.2 Europe Veterinary Drugs Contract Manufacturing 麻豆原创 Size by Type (2020-2025)
7.3 Europe Veterinary Drugs Contract Manufacturing 麻豆原创 Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Veterinary Drugs Contract Manufacturing by Region (2020-2025)
8.2 Middle East & Africa Veterinary Drugs Contract Manufacturing 麻豆原创 Size by Type (2020-2025)
8.3 Middle East & Africa Veterinary Drugs Contract Manufacturing 麻豆原创 Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 麻豆原创 Drivers, Challenges and Trends
9.1 麻豆原创 Drivers & Growth Opportunities
9.2 麻豆原创 Challenges & Risks
9.3 Industry Trends
10 Global Veterinary Drugs Contract Manufacturing 麻豆原创 Forecast
10.1 Global Veterinary Drugs Contract Manufacturing Forecast by Region (2026-2031)
10.1.1 Global Veterinary Drugs Contract Manufacturing Forecast by Region (2026-2031)
10.1.2 Americas Veterinary Drugs Contract Manufacturing Forecast
10.1.3 APAC Veterinary Drugs Contract Manufacturing Forecast
10.1.4 Europe Veterinary Drugs Contract Manufacturing Forecast
10.1.5 Middle East & Africa Veterinary Drugs Contract Manufacturing Forecast
10.2 Americas Veterinary Drugs Contract Manufacturing Forecast by Country (2026-2031)
10.2.1 United States 麻豆原创 Veterinary Drugs Contract Manufacturing Forecast
10.2.2 Canada 麻豆原创 Veterinary Drugs Contract Manufacturing Forecast
10.2.3 Mexico 麻豆原创 Veterinary Drugs Contract Manufacturing Forecast
10.2.4 Brazil 麻豆原创 Veterinary Drugs Contract Manufacturing Forecast
10.3 APAC Veterinary Drugs Contract Manufacturing Forecast by Region (2026-2031)
10.3.1 China Veterinary Drugs Contract Manufacturing 麻豆原创 Forecast
10.3.2 Japan 麻豆原创 Veterinary Drugs Contract Manufacturing Forecast
10.3.3 Korea 麻豆原创 Veterinary Drugs Contract Manufacturing Forecast
10.3.4 Southeast Asia 麻豆原创 Veterinary Drugs Contract Manufacturing Forecast
10.3.5 India 麻豆原创 Veterinary Drugs Contract Manufacturing Forecast
10.3.6 Australia 麻豆原创 Veterinary Drugs Contract Manufacturing Forecast
10.4 Europe Veterinary Drugs Contract Manufacturing Forecast by Country (2026-2031)
10.4.1 Germany 麻豆原创 Veterinary Drugs Contract Manufacturing Forecast
10.4.2 France 麻豆原创 Veterinary Drugs Contract Manufacturing Forecast
10.4.3 UK 麻豆原创 Veterinary Drugs Contract Manufacturing Forecast
10.4.4 Italy 麻豆原创 Veterinary Drugs Contract Manufacturing Forecast
10.4.5 Russia 麻豆原创 Veterinary Drugs Contract Manufacturing Forecast
10.5 Middle East & Africa Veterinary Drugs Contract Manufacturing Forecast by Region (2026-2031)
10.5.1 Egypt 麻豆原创 Veterinary Drugs Contract Manufacturing Forecast
10.5.2 South Africa 麻豆原创 Veterinary Drugs Contract Manufacturing Forecast
10.5.3 Israel 麻豆原创 Veterinary Drugs Contract Manufacturing Forecast
10.5.4 Turkey 麻豆原创 Veterinary Drugs Contract Manufacturing Forecast
10.6 Global Veterinary Drugs Contract Manufacturing Forecast by Type (2026-2031)
10.7 Global Veterinary Drugs Contract Manufacturing Forecast by Application (2026-2031)
10.7.1 GCC Countries 麻豆原创 Veterinary Drugs Contract Manufacturing Forecast
11 Key Players Analysis
11.1 Vetio
11.1.1 Vetio Company Information
11.1.2 Vetio Veterinary Drugs Contract Manufacturing Product Offered
11.1.3 Vetio Veterinary Drugs Contract Manufacturing Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.1.4 Vetio Main Business Overview
11.1.5 Vetio Latest Developments
11.2 AlphaVet Export
11.2.1 AlphaVet Export Company Information
11.2.2 AlphaVet Export Veterinary Drugs Contract Manufacturing Product Offered
11.2.3 AlphaVet Export Veterinary Drugs Contract Manufacturing Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.2.4 AlphaVet Export Main Business Overview
11.2.5 AlphaVet Export Latest Developments
11.3 Fabbrica Italiana Sintetici
11.3.1 Fabbrica Italiana Sintetici Company Information
11.3.2 Fabbrica Italiana Sintetici Veterinary Drugs Contract Manufacturing Product Offered
11.3.3 Fabbrica Italiana Sintetici Veterinary Drugs Contract Manufacturing Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.3.4 Fabbrica Italiana Sintetici Main Business Overview
11.3.5 Fabbrica Italiana Sintetici Latest Developments
11.4 Veto-pharma
11.4.1 Veto-pharma Company Information
11.4.2 Veto-pharma Veterinary Drugs Contract Manufacturing Product Offered
11.4.3 Veto-pharma Veterinary Drugs Contract Manufacturing Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.4.4 Veto-pharma Main Business Overview
11.4.5 Veto-pharma Latest Developments
11.5 Parnell
11.5.1 Parnell Company Information
11.5.2 Parnell Veterinary Drugs Contract Manufacturing Product Offered
11.5.3 Parnell Veterinary Drugs Contract Manufacturing Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.5.4 Parnell Main Business Overview
11.5.5 Parnell Latest Developments
11.6 Medical Products Laboratories
11.6.1 Medical Products Laboratories Company Information
11.6.2 Medical Products Laboratories Veterinary Drugs Contract Manufacturing Product Offered
11.6.3 Medical Products Laboratories Veterinary Drugs Contract Manufacturing Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.6.4 Medical Products Laboratories Main Business Overview
11.6.5 Medical Products Laboratories Latest Developments
11.7 Univet
11.7.1 Univet Company Information
11.7.2 Univet Veterinary Drugs Contract Manufacturing Product Offered
11.7.3 Univet Veterinary Drugs Contract Manufacturing Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.7.4 Univet Main Business Overview
11.7.5 Univet Latest Developments
11.8 Oxi Pharma
11.8.1 Oxi Pharma Company Information
11.8.2 Oxi Pharma Veterinary Drugs Contract Manufacturing Product Offered
11.8.3 Oxi Pharma Veterinary Drugs Contract Manufacturing Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.8.4 Oxi Pharma Main Business Overview
11.8.5 Oxi Pharma Latest Developments
11.9 Sterling Pharmaceutical Services
11.9.1 Sterling Pharmaceutical Services Company Information
11.9.2 Sterling Pharmaceutical Services Veterinary Drugs Contract Manufacturing Product Offered
11.9.3 Sterling Pharmaceutical Services Veterinary Drugs Contract Manufacturing Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.9.4 Sterling Pharmaceutical Services Main Business Overview
11.9.5 Sterling Pharmaceutical Services Latest Developments
11.10 ACME Drugs
11.10.1 ACME Drugs Company Information
11.10.2 ACME Drugs Veterinary Drugs Contract Manufacturing Product Offered
11.10.3 ACME Drugs Veterinary Drugs Contract Manufacturing Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.10.4 ACME Drugs Main Business Overview
11.10.5 ACME Drugs Latest Developments
11.11 Kela Health
11.11.1 Kela Health Company Information
11.11.2 Kela Health Veterinary Drugs Contract Manufacturing Product Offered
11.11.3 Kela Health Veterinary Drugs Contract Manufacturing Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.11.4 Kela Health Main Business Overview
11.11.5 Kela Health Latest Developments
11.12 Friulchem S.p.A.
11.12.1 Friulchem S.p.A. Company Information
11.12.2 Friulchem S.p.A. Veterinary Drugs Contract Manufacturing Product Offered
11.12.3 Friulchem S.p.A. Veterinary Drugs Contract Manufacturing Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.12.4 Friulchem S.p.A. Main Business Overview
11.12.5 Friulchem S.p.A. Latest Developments
11.13 Sypharma Pty Ltd
11.13.1 Sypharma Pty Ltd Company Information
11.13.2 Sypharma Pty Ltd Veterinary Drugs Contract Manufacturing Product Offered
11.13.3 Sypharma Pty Ltd Veterinary Drugs Contract Manufacturing Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.13.4 Sypharma Pty Ltd Main Business Overview
11.13.5 Sypharma Pty Ltd Latest Developments
11.14 Safapac
11.14.1 Safapac Company Information
11.14.2 Safapac Veterinary Drugs Contract Manufacturing Product Offered
11.14.3 Safapac Veterinary Drugs Contract Manufacturing Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.14.4 Safapac Main Business Overview
11.14.5 Safapac Latest Developments
11.15 Custom Veterinary Services
11.15.1 Custom Veterinary Services Company Information
11.15.2 Custom Veterinary Services Veterinary Drugs Contract Manufacturing Product Offered
11.15.3 Custom Veterinary Services Veterinary Drugs Contract Manufacturing Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.15.4 Custom Veterinary Services Main Business Overview
11.15.5 Custom Veterinary Services Latest Developments
11.16 LABIANA
11.16.1 LABIANA Company Information
11.16.2 LABIANA Veterinary Drugs Contract Manufacturing Product Offered
11.16.3 LABIANA Veterinary Drugs Contract Manufacturing Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.16.4 LABIANA Main Business Overview
11.16.5 LABIANA Latest Developments
11.17 Nedulix Biotech Private Limited
11.17.1 Nedulix Biotech Private Limited Company Information
11.17.2 Nedulix Biotech Private Limited Veterinary Drugs Contract Manufacturing Product Offered
11.17.3 Nedulix Biotech Private Limited Veterinary Drugs Contract Manufacturing Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.17.4 Nedulix Biotech Private Limited Main Business Overview
11.17.5 Nedulix Biotech Private Limited Latest Developments
11.18 Argenta Global
11.18.1 Argenta Global Company Information
11.18.2 Argenta Global Veterinary Drugs Contract Manufacturing Product Offered
11.18.3 Argenta Global Veterinary Drugs Contract Manufacturing Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.18.4 Argenta Global Main Business Overview
11.18.5 Argenta Global Latest Developments
11.19 Altar Life Sciences
11.19.1 Altar Life Sciences Company Information
11.19.2 Altar Life Sciences Veterinary Drugs Contract Manufacturing Product Offered
11.19.3 Altar Life Sciences Veterinary Drugs Contract Manufacturing Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.19.4 Altar Life Sciences Main Business Overview
11.19.5 Altar Life Sciences Latest Developments
12 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.